DALLAS, April 06, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, advanced its Environmental, Social, and Governance (ESG) commitments in 2022, leading the industry in social impact and sustainability.
“Our commitment to ESG has become central to our culture and our business – it’s who we are. We're passionate about partnering with our team members, clients, healthcare professionals, suppliers, and other stakeholders to accelerate our vision of a healthy, just, equitable, and sustainable world where all can thrive," said AMN Healthcare President and CEO Cary Grace. “We aim to be a catalyst for change as we prioritize our social impact, collaborate across our value chain, and ensure ESG is foundational to the team members who drive our impact.”
AMN Healthcare is also working to develop and diversify the healthcare professional pipeline, drive diversity in its healthcare leadership placements, and increase the diversity of its team members at all levels. The company’s impact on the world is fueled by its diverse workforce’s daily efforts to support and enable clients and healthcare professionals to provide access and high-quality care to patients and communities. The company promoted health equity through investments in healthcare workforce diversity and resilience, and in programs that increase access to healthcare for marginalized groups.
To manage and reduce its environmental impacts, AMN Healthcare has measured its full Scope 1, 2, and 3 greenhouse gas emissions (GHG emissions), and has successfully decreased its direct operational GHG emissions by 34% since 2019.
Highlights from the 2022 AMN Healthcare ESG Report:
Social (Health & DEI):
Governance:
Environmental:
View the full AMN Healthcare 2022 ESG Report.
About AMN Healthcare
AMN Healthcare is the leader and innovator in total talent solutions for healthcare organizations across the nation. The Company provides access to the most comprehensive network of quality healthcare professionals through its innovative recruitment strategies and breadth of career opportunities. With insights and expertise, AMN Healthcare helps providers optimize their workforce to successfully reduce complexity, increase efficiency and improve patient outcomes. AMN total talent solutions include managed services programs, clinical and interim healthcare leaders, temporary staffing, executive search solutions, vendor management systems, recruitment process outsourcing, predictive modeling, language interpretation services, revenue cycle solutions, credentialing, and other services. Clients include acute-care hospitals, community health centers and clinics, physician practice groups, retail and urgent care centers, home health facilities, schools and many other healthcare settings. AMN Healthcare is committed to fostering and maintaining a diverse team that reflects the communities we serve. Our commitment to the inclusion of many different backgrounds, experiences and perspectives enables our innovation and leadership in the healthcare services industry. For more information about AMN Healthcare, visit www.amnhealthcare.com.
Media Contact
Jim Gogek
Corporate Communications
AMN Healthcare
(858) 350-3209
This email address is being protected from spambots. You need JavaScript enabled to view it.
Investor Contact
Randle Reece
Director, Investor Relations
AMN Healthcare
(866) 861-3229
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$25.56 |
Daily Change: | 0.42 1.67 |
Daily Volume: | 727,238 |
Market Cap: | US$973.070M |
February 20, 2025 November 07, 2024 August 27, 2024 August 08, 2024 July 09, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load